TERMINATION AGREEMENTTermination Agreement • July 25th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Termination Agreement (this “Termination Agreement”) is entered into by and between Dr. Paul Finnegan (“Consultant”) and Imprimis Pharmaceuticals, Inc. (the “Company”), effective as of May 9, 2012.
AMENDMENT TO ADVISORY AGREEMENTAdvisory Agreement • July 25th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Amendment to Advisory Agreement (this “Amendment”), dated July 24, 2012 (the “Effective Date”), is entered into by and between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Dr. Robert J. Kammer, an individual (the “Consultant”).
FIRST AMENDED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 25th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations
This First Amended Securities Purchase Agreement (this “Amended Agreement”) is dated as of December 31, 2011 (and made effective as of November 21, 2011), between Transdel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and DermaStar International, LLC (the “Purchaser”).
IMPRIMIS PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 25th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 24, 2012 (the “Effective Date”), by and between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Mark L. Baum (“Executive”), and amends and restates in its entirety that Employment Agreement entered into by and between the Company and Executive, dated as of April 1, 2012 (as amended, the “Existing Agreement"):
CONVERSION AGREEMENTConversion Agreement • July 25th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Conversion Agreement ("Agreement") is dated this 29th of June, 2012 (the “Effective Date”) by and between DermaStar International, LLC, a limited liability company ("DermaStar"), and Imprimis Pharmaceuticals, Inc., a Delaware corporation, (the "Company"). DermaStar and the Company shall individually be referred to as a “Party” and collectively as the “Parties.”
